• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗凝血酶III浓缩物和抗聚集剂在肺结核患者术前准备中的应用]

[The use of a concentrate of antithrombin III and disaggregants in the preoperative preparation of patients with pulmonary tuberculosis].

作者信息

Priĭmak A A, Makinskiĭ A I, Ivan'ko T P, Makarova V V

出版信息

Vrach Delo. 1990 May(5):73-4.

PMID:2396401
Abstract

A study of the blood coagulation system in 32 patients with pulmonary tuberculosis before surgical intervention showed that reduction of the antithrombine III activity and related enhancement of the thrombin formation reaction and suppression of deaggregation capacities of thrombocytes reflect the latent process of pathological intravascular blood coagulation. The authors suggest justification of restoring the reduced antithrombine blood capacitance and normalization of the deaggregation capacity of thrombocytes by means of the antithrombine III concentrate and disaggregants in the complex preoperative care.

摘要

一项针对32例肺结核患者手术干预前凝血系统的研究表明,抗凝血酶III活性降低、凝血酶形成反应相关增强以及血小板解聚能力受抑制,反映了病理性血管内凝血的潜在过程。作者建议在术前综合护理中,通过使用抗凝血酶III浓缩剂和血小板解聚剂来恢复降低的抗凝血酶血容量和使血小板解聚能力正常化是合理的。

相似文献

1
[The use of a concentrate of antithrombin III and disaggregants in the preoperative preparation of patients with pulmonary tuberculosis].[抗凝血酶III浓缩物和抗聚集剂在肺结核患者术前准备中的应用]
Vrach Delo. 1990 May(5):73-4.
2
[The hemostatic system in patients with pulmonary tuberculosis during their preparation for surgery].[肺结核患者手术准备期间的止血系统]
Probl Tuberk. 1991(8):39-42.
3
[The correction of disorders in the blood coagulating system during the surgical treatment of patients with pulmonary tuberculosis].[肺结核患者外科治疗期间血液凝固系统紊乱的纠正]
Vrach Delo. 1991 Sep(9):54-7.
4
[Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
Anesteziol Reanimatol. 2007 Mar-Apr(2):42-4.
5
[Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].[颅内出血与止血。通过测定和随访凝血激活产物对颅内出血患者进行监测]
Infusionsther Transfusionsmed. 1994 Aug;21(4):244-50.
6
Antithrombin III infusion in patients undergoing peritoneovenous shunt operation: failure in the prevention of disseminated intravascular coagulation.接受腹腔静脉分流手术患者输注抗凝血酶III:预防弥散性血管内凝血失败。
Thromb Haemost. 1983 Apr 28;49(2):128-31.
7
Recovery of antithrombin III in patients undergoing orthotopic liver transplantation after administration of an antithrombin III concentrate.给予抗凝血酶III浓缩物后原位肝移植患者抗凝血酶III的恢复情况。
Semin Thromb Hemost. 1993;19(3):309-10. doi: 10.1055/s-2007-994049.
8
[Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
Hokkaido Igaku Zasshi. 1987 Jan;62(1):108-21.
9
[Arteriovenous differences in the state of the hemostasis system of patients with pulmonary tuberculosis].[肺结核患者止血系统状态的动静脉差异]
Probl Tuberk. 1992(1-2):10-3.
10
Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
Acta Chir Scand Suppl. 1982;509:105-7.